🇺🇸 FDA
Pipeline program

Placebo

LX4211.1-206-T1DM

Phase 3 small_molecule completed

Quick answer

Placebo for Type 1 Diabetes Mellitus is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
LEXICON PHARMACEUTICALS, INC.
Indication
Type 1 Diabetes Mellitus
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials